Received Jun 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5895B | — |
administration in a 2 month old; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old female patient who received DTPa-IPV (Kinrix) (batch number 5895B, expiry date 16-FEB-2026) for prophylaxis. On 10-JUN-2025, the patient received Kinrix. On 10-JUN-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: administration in a 2-month-old). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 10-JUN-2025 The reporter reported that 2-month-old patient received Kinrix vaccine which led to, inappropriate age at vaccine administration. The Vaccine Administration Facility is the same as Primary Reporter.